Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial

Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:24:00.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has removed significant content regarding a clinical trial for GNbAC1 in patients with relapsing-remitting multiple sclerosis, including details about the trial's design, inclusion and exclusion criteria, and collaborators. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    13%
    Check dated 2025-04-16T14:24:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:15:45.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:47:54.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:52:36.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T08:33:46.000Z thumbnail image

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.